Prestige Brands Holdings

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

PBH reports record fiscal 2023 results, addresses inflation challenges

PBH's strong fiscal 2023 performance was highlighted, but challenges from inflation and foreign currency headwinds were acknowledged. The company is focused on leveraging opportunities for growth and remains committed to its long-term goals.

PBH reports resilient Q1 performance, anticipates high single-digit Q2 growth

PBH's Q1 performance demonstrated resilience with strong sales and margin improvements. While facing challenges in EBITDA and gross margin, the company's strategic focus on brand growth, debt reduction, and share buyback program positions it well for future opportunities. With a reaffirmed full-year outlook and anticipated Q2 growth, PBH remains focused on sustainable growth and financial discipline.

Prestige Brands reports solid Q3 earnings, eyes growth opportunities

Prestige Brands Holdings (PBH) delivered a solid performance in Q3 2023, driven by strong revenue growth, profitability, and strategic financial management.
While facing challenges such as gross margin decline and industry-wide inflationary pressures, the company remains focused on cost management and pricing strategies to sustain growth.
With opportunities for revenue growth, operational efficiency, and strategic planning in fiscal 2024, Prestige Brands is well-positioned for continued success and value creation.

Prestige Brands Holdings reports record fiscal '23 results and outlines growth strategies for fiscal '24

Prestige Brands Holdings delivered strong financial results in fiscal '23, with robust revenue growth and adjusted EPS. The company is focused on maintaining margins, reducing leverage, and capitalizing on growth opportunities in key segments. Management's strategic outlook for fiscal '24 includes revenue projections, EPS targets, and a commitment to disciplined capital allocation.

Prestige Brands Holdings (PBH) surpasses Q1 expectations amidst challenges

PBH's Q1 performance exceeded expectations with strong organic sales growth and improved gross margin despite cost pressures.
While facing challenges from cost increases and debt levels, PBH maintains a solid financial position with strong cash flow.
Opportunities lie in sustained revenue growth, market expansion, and operational efficiency enhancements for PBH in the coming quarters.

Prestige Brands reports robust Q2 results, eyes international growth

Prestige Brands Holdings delivered a solid performance in Q2, driven by strong sales, EPS growth, and debt reduction.
While facing challenges in North America and margin pressure, the company's international growth and e-commerce focus present opportunities for future expansion.
Maintaining a healthy financial position with strong cash flow and reaffirming full-year outlook underscores Prestige Brands' stability and growth potential.
Strategic management of expenses and leveraging brand success will be crucial for sustained growth and profitability in the competitive consumer goods market.

Prestige Brands Holdings reports solid Q3 performance and eyes growth

Prestige Brands Holdings delivered a strong Q3 performance with revenue exceeding expectations and a focus on maintaining market share and brand differentiation.
The company's financial discipline led to debt reduction and healthy free cash flow, while challenges include inventory coverage issues and evaluating M&A opportunities.
Opportunities for growth include exploring potential M&A deals, focusing on long-term financial targets, and capitalizing on international and North American segment growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American and International OTC Healthcare segments manage the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

This comes as 72% of Americans say they prefer someone else handle the planning for them, and nearly a third of Americans saying their plans won't be finalized until weeks before. This comes as 72% of Americans say they prefer someone else handle the planning for them, and nearly a third of Americans saying their plans won't be finalized until weeks before.

Dramamine® Eases Americans' Travel Woes with ‘Ditch the Drama' Sweepstakes Offering a Vacation to Anywhere in the World

Prestige Consumer's (PBH) fourth-quarter fiscal 2023 results reflect gains from the company's diversified portfolio and brand-building efforts.

Prestige Consumer (PBH) Q4 Earnings Top Estimates, Revenues Up

Prestige Brands (PBH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $0.91 per share a year ago.

Prestige Brands (PBH) Beats Q4 Earnings and Revenue Estimates

TARRYTOWN, N.Y., May 04, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2023.

Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023

Prestige Consumer's (PBH) fourth-quarter fiscal 2023 earnings are likely to have gained from brand-building strategies and robust e-commerce business.

What's in Store for Prestige Consumer (PBH) in Q4 Earnings?

Traeger

Genius Brands

The RealReal

Prestige Consumer Healthcare (PBH), Traeger (COOK), The RealReal (REAL) and Genius Brands (GNUS) have been focusing on a superior product strategy and prudent capital investments.

4 Stocks to Track Despite Consumer Products-Discretionary Industry Woes

The stock price of Prestige Consumer Healthcare Inc (NYSE: PBH) fell by 7.06% this past week. This is why.

PBH Stock: 7.06% Decrease This Week Explained

Prestige Consumer's (PBH) third-quarter fiscal 2023 results reflect strength in the Cough and Cold category and a solid International OTC segment performance.

Prestige Consumer (PBH) Q3 Earnings & Revenues Top Estimates

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ET Company Participants Phil Terpolilli - Vice President of Investor Relations & Treasurer Ronald Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer and Company Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co Linda Bolton Weiser - D.A. Davidson Operator Good day and thank you for standing by.

Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript

Prestige Brands (PBH) delivered earnings and revenue surprises of 2.97% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Brands (PBH) Q3 Earnings and Revenues Surpass Estimates

TARRYTOWN, N.Y., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third fiscal quarter ended December 31, 2022.

Prestige Consumer Healthcare Inc. Reports Third Quarter Results

Prestige Consumer (PBH) third-quarter fiscal 2023 earnings might reflect gains from brand-building strategies, e-commerce business and market share gains.

Prestige Consumer (PBH) to Post Q3 Earnings: Factors to Consider

TARRYTOWN, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 third quarter earnings release on Thursday, February 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results

Central Garden & Pet Company

Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.

4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q2 2023 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Co. Jon Andersen - William Blair Operator Good day and thank you for standing by. Welcome to the Prestige Consumer Healthcare Second Quarter Earnings Conference Call.

Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript

Premium Brands Holdings Corporation (OTCPK:PRBZF) Q3 2022 Earnings Conference Call November 3, 2022 1:30 PM ET Company Participants George Paleologou - President & Chief Executive Officer Will Kalutycz - Chief Financial Officer Conference Call Participants Derek Lessard - TD Securities George Doumet - Scotiabank Martin Landry - Stifel GMP Stephen MacLeod - BMO Capital Markets John Zamparo - CIBC Capital Markets Vishal Shreedhar - National Bank Financial Kyle McPhee - Cormark Securities Derek Lessard - TD Securities Operator Good afternoon, ladies and gentlemen, and welcome to the Premium Brands Holdings Corporation Third Quarter 2022 Earnings Conference Call. At this time, all lines are in listen only mode.

Premium Brands Holdings Corporation (PRBZF) Q3 2022 Earnings Call Transcript

Prestige Consumer's (PBH) second-quarter fiscal 2023 results were backed by strength in its brand portfolio and solid business strategy.

Prestige Consumer (PBH) Q2 Earnings Beat Mark, Revenues Rise

Prestige Brands (PBH) delivered earnings and revenue surprises of 2% and 2.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Brands (PBH) Tops Q2 Earnings and Revenue Estimates

TARRYTOWN, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second fiscal quarter ended September 30, 2022.

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

Prestige Consumer's (PBH) second-quarter fiscal 2023 earnings results might reflect the impacts of a tough operating landscape, including supply-chain headwinds and higher costs.

Factors to Know Ahead of Prestige Consumer (PBH) Q2 Earnings

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Prestige Brands (PBH) Q2 Earnings Expected to Decline

TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

Hyatt Hotels

InterContinental Hotels Group

Target Hospitality Corp

Marriott Vacations Worldwide

Despite rising costs, people are spending aggressively as personal income is on the rise, helping stocks like Marriott Vacations (VAC), Hyatt Hotels (H), Prestige Consumer Healthcare (PBH), InterContinental Hotels (IHG) and Target Hospitality (TH).

5 Stocks to Buy on Rise in Personal Income, Personal Spending

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Prestige Brands (PBH) is a Strong Value Stock

On Holding AG

RCI Hospitality

Stocks like Prestige Consumer Healthcare Inc. (PBH), RCI Hospitality Holdings, Inc. (RICK), Hyatt Hotels Corporation (H) and On Holding AG (ONON) may gain as Americans seem to be regaining their lost confidence.

News for Prestige Brands Holdings Stock (PBH)